The Christie NHS Foundation Trust
Director of Pharmacy
Rob Duncombe. Director of Pharmacy at the Christie NHS Foundation Trust in Manchester. A member of a number of national groups associated with pharmacy practice and medicines optimisation. Closely involved in recent initiates in the UK around the introduction of biosimilars in cancer; national dose banding of chemotherapy; and a radical approach to managing oral chemotherapy treatments.
Medicine Optimisation in Oncology. How to achieve best value.
Expenditure on the drugs we use in cancer is increasing every year. This is a function of both demographics and a paradigm shift in how we treat cancer. It is therefore extremely important that we optimise the use of cancer medicines and eliminate waste.
EVEN MORE SEMINARS
Professor A. Graham Pockley multimmune GmbH / Nottingham Trent University
A new era of cancer therapeutics?
Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath University Hospital Southampton NHS Foundation Trust.
Targeted therapies: aiming at the tumour micro-environment
Glenn Flux Royal Marsden Hospital
The emergence and resurgence of radiotherapeutics for cancer treatment
Philip Beer MRCP, FRCPath, PhD ONCODNA S.A
The evolution of oncology therapeutics in the genomic era.
Mr Naga Venkatesh Jayanthi MD, FRCS Bupa - Consultant Surgeon
Minimal Invasive Oesophagectomy – where are we going?